Latest Period
Q1 2026
Security Snapshot
AEON Biopharma, Inc. - Common Stock (AEON) Institutional Ownership
CUSIP: 00791X209
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
24
Shares (Excl. Options)
2,841,419
Price
$0.99
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- AEON on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 2,841,419
- Total 13F value
- $2,800,888
- Portfolio coverage rank
- 0%
- Share change
- +393,423
- Value change
- +$384,975
- Number of holders
- 24
- Shares outstanding
- 11,898,571
- SEC-reported price per share
- $0.86
- Insider filing price
- $0.86
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AEON - AEON Biopharma, Inc. - Common Stock is tracked under CUSIP 00791X209.
- 24 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 22 to 24 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,667,217 to $2,800,888.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 24 institutions filings for Q1 2026.
Security key
00791X209
Latest holder period
Q1 2026
13F holders
24
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
AEON full holder history
AEON Biopharma, Inc. SEC filings
AEON Biopharma, Inc. company facts
AEON Biopharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00791X209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
AEON
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Chernett Jorey | 9.9% | $564,250 | 1,128,500 | Chernett Jorey | 27 May 2025 | |||
| Alta Partners LLC | 2.1% | -60% | $192,400 | -$259,078 | 249,870 | -57% | Alta Partners LLC | 30 Sep 2025 |
| Dauntless Investment Group, LLC | 9.7% | $44,372 | 108,224 | Dauntless Investment Group, LLC | 26 Feb 2025 |
As of 31 Mar 2026, 24 institutional investors reported holding 2,841,419 shares of AEON Biopharma, Inc. - Common Stock (AEON). This represents 24% of the company’s total 11,898,571 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
24%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 21% | 2,527,775 | +19% | 7% | $2,489,858 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.76% | 90,529 | 0% | 0% | $89,171 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.73% | 87,062 | +45% | 0% | $85,755 |
| Blue Owl Capital Holdings LP | 0.36% | 42,353 | -2.4% | 0.01% | $41,506 |
| XTX Topco Ltd | 0.17% | 20,424 | -64% | 0% | $20,118 |
| Formidable Asset Management, LLC | 0.17% | 20,024 | 0% | $22,026 | |
| JANE STREET GROUP, LLC | 0.14% | 16,376 | 0% | $16,130 | |
| VANGUARD FIDUCIARY TRUST CO | 0.12% | 14,702 | 0% | 0% | $14,481 |
| LPL Financial LLC | 0.1% | 11,507 | 0% | $11,334 | |
| UBS Group AG | 0.04% | 4,182 | +3.2% | 0% | $4,120 |
| BlackRock, Inc. | 0.02% | 2,834 | 0% | 0% | $2,791 |
| Steward Partners Investment Advisory, LLC | 0.01% | 1,100 | +1000% | 0% | $1,084 |
| CITIGROUP INC | 0.01% | 742 | 0% | $731 | |
| WOLFF WIESE MAGANA LLC | 0% | 567 | 0% | 0% | $559 |
| Tower Research Capital LLC (TRC) | 0% | 470 | 0% | $463 | |
| DUPONT CAPITAL MANAGEMENT CORP | 0% | 170 | 0% | 0% | $167 |
| MORGAN STANLEY | 0% | 150 | 0% | 0% | $148 |
| SBI Securities Co., Ltd. | 0% | 105 | 0% | 0% | $103 |
| Vanguard Global Advisers, LLC | 0% | 102 | 0% | 0% | $100 |
| GHP Investment Advisors, Inc. | 0% | 95 | 0% | 0% | $94 |
| WELLS FARGO & COMPANY/MN | 0% | 90 | 0% | 0% | $89 |
| MAI Capital Management | 0% | 58 | 0% | 0% | $58 |
| Caitong International Asset Management Co., Ltd | 0% | 1 | 0% | $1 | |
| DANSKE BANK A/S | 0% | 1 | 0% | 0% | $1 |
| Laird Norton Wetherby Trust Company, LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q1 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,841,419 | $2,800,888 | +$384,975 | $0.99 | 24 |
| 2025 Q4 | 2,443,029 | $1,667,217 | +$712,814 | $1.10 | 22 |
| 2025 Q3 | 1,364,447 | $1,103,333 | +$78,032 | $0.81 | 21 |
| 2025 Q2 | 1,271,217 | $585,730 | -$147,232 | $0.76 | 18 |
| 2025 Q1 | 1,526,776 | $884,785 | +$884,785 | $0.58 | 15 |